Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
Recruiting now
Conditions studied: Breast Cancer Screening
In brief
The purpose of this study is to construct an auxiliary diagnostic model for breast cancer by methylation markers. The study will collect blood and tissue samples from participants with breast cancer and benign disease for whole-genome methylation sequencing. It will screen methylation markers and develop a methylation auxiliary diagnosis model to distinguish between breast cancer and non-cancer.
Key facts
- Study ID
- NCT06876610
- Run by
- Geneplus-Beijing Co. Ltd.
- People needed
- 200
- Starts
- 2025-03-15
- Expected to finish
- 2026-08-31
- Last updated by the study team
- 2025-03-14
Who can join
Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences — Beijing, Beijing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.